Literature DB >> 28183530

TNFΔARE Mice Display Abnormal Lymphatics and Develop Tertiary Lymphoid Organs in the Mesentery.

Sonia Rehal1, Pierre-Yves von der Weid2.   

Abstract

Chronic inflammatory diseases are associated with a persistent and enhanced response to environmental antigens. As an adaptive response to this exaggerated immune state, affected tissue typically develops tertiary lymphoid organs. Studies of Crohn disease (CD), a chronic inflammatory disease of the intestinal tract, report tertiary lymphoid organs present within the mucosal wall, along with other lymphatic diseases, such as lymphangiogenesis and obstructed lymphatic vessels. These observations suggest that downstream mesenteric lymphatic vessels and lymph drainage into mesenteric lymph nodes may be compromised. However, information is lacking on the morphologic features and functional status of mesenteric lymphatics in CD. Using confocal imaging, PCR, flow cytometry, and functional strategies, we addressed these questions in the established TNFΔARE mouse model of CD and found that this mouse model had many lymphatic abnormalities reminiscent of human CD. These abnormalities include intestinal lymphangiectasia, mesenteric lymph node lymphadenopathy, and lymphangiogenesis in both the mesentery and mucosa. Critically, TNFΔARE mice also present mesenteric tertiary lymphoid organs and have altered lymphatic transport of dendritic cells to mesenteric lymph nodes, two features likely to actively modulate immunity. Our findings provide key insights into lymphatic remodeling in the TNFΔARE mouse model. They shed light on the involvement of these lymphatic changes in immune dysfunctions observed in CD and suggest the lymphatic system as new target for therapeutic options.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28183530      PMCID: PMC5397719          DOI: 10.1016/j.ajpath.2016.12.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease.

Authors:  E Kaiserling
Journal:  Lymphology       Date:  2001-03       Impact factor: 1.286

Review 2.  Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome.

Authors:  Thomas Dörner; Arne Hansen; Annett Jacobi; Peter E Lipsky
Journal:  Autoimmun Rev       Date:  2002-05       Impact factor: 9.754

Review 3.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels.

Authors:  Gwendalyn J Randolph; Veronique Angeli; Melody A Swartz
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

4.  Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease.

Authors:  Gwendalyn J Randolph; Shashi Bala; Jean-François Rahier; Michael W Johnson; Peter L Wang; ILKe Nalbantoglu; Laurent Dubuquoy; Amélie Chau; Benjamin Pariente; Alex Kartheuser; Bernd H Zinselmeyer; Jean-Frederic Colombel
Journal:  Am J Pathol       Date:  2016-10-13       Impact factor: 4.307

5.  Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis.

Authors:  Ryan Mathias; Pierre-Yves von der Weid
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

Review 6.  Emerging roles of lymphatics in inflammatory bowel disease.

Authors:  J Steven Alexander; Ganta Vijay Chaitanya; M B Grisham; Moheb Boktor
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Dextran sulfate sodium induces pan-gastroenteritis in rodents: implications for studies of colitis.

Authors:  W Elsheikh; K L Flannigan; W McKnight; J G P Ferraz; J L Wallace
Journal:  J Physiol Pharmacol       Date:  2012-10       Impact factor: 3.011

Review 8.  Lymphoid neogenesis in chronic inflammatory diseases.

Authors:  Francesca Aloisi; Ricardo Pujol-Borrell
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

9.  Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40.

Authors:  F Pedica; C Ligorio; P Tonelli; S Bartolini; P Baccarini
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

10.  Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation.

Authors:  M K Magnusson; S F Brynjólfsson; A Dige; H Uronen-Hansson; L G Börjesson; J L Bengtsson; S Gudjonsson; L Öhman; J Agnholt; H Sjövall; W W Agace; M J Wick
Journal:  Mucosal Immunol       Date:  2015-06-17       Impact factor: 7.313

View more
  8 in total

1.  Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner.

Authors:  Matthew Stephens; Pierre-Yves von der Weid
Journal:  Gut Microbes       Date:  2019-06-16

Review 2.  Adipose tissue microenvironments during aging: Effects on stimulated lipolysis.

Authors:  Christina D Camell
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-02-05       Impact factor: 4.698

3.  Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor.

Authors:  Rafael S Czepielewski; Emma C Erlich; Emily J Onufer; Shannon Young; Brian T Saunders; Yong-Hyun Han; Mary Wohltmann; Peter L Wang; Ki-Wook Kim; Shashi Kumar; Chyi-Song Hsieh; Joshua P Scallan; Ying Yang; Bernd H Zinselmeyer; Michael J Davis; Gwendalyn J Randolph
Journal:  Immunity       Date:  2021-11-16       Impact factor: 31.745

4.  Mesenteric Lymphatic Vessel Density Is Associated with Disease Behavior and Postoperative Recurrence in Crohn's Disease.

Authors:  Yi Li; Yuanyuan Ge; Jianfeng Gong; Weiming Zhu; Lei Cao; Zhen Guo; Lili Gu; Jieshou Li
Journal:  J Gastrointest Surg       Date:  2018-07-24       Impact factor: 3.452

5.  Mesenteric Lymphatic Alterations Observed During DSS Induced Intestinal Inflammation Are Driven in a TLR4-PAMP/DAMP Discriminative Manner.

Authors:  Matthew Stephens; Shan Liao; Pierre-Yves von der Weid
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

6.  DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone.

Authors:  Corinne E Metzger; S Anand Narayanan; Jon P Elizondo; Anne Michal Carter; David C Zawieja; Harry A Hogan; Susan A Bloomfield
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

Review 7.  Trafficking and retention of protein antigens across systems and immune cell types.

Authors:  Thu A Doan; Tadg Forward; Beth A Jirón Tamburini
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.207

Review 8.  Fluorescent Tracers for In Vivo Imaging of Lymphatic Targets.

Authors:  P S Russell; R Velivolu; V E Maldonado Zimbrón; J Hong; I Kavianinia; A J R Hickey; J A Windsor; A R J Phillips
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.